NGNatalia García-San-Martín

Natalia García-San-Martín

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Natalia García-San-Martín has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Rafael Romero García

    Department of Psychiatry, University of Cambridge, Cambridge, UK

    9 shared publications
  • Benedicto Crespo-Facorro

    Mental Health Service, Virgen del Rocío University Hospital; Seville, Spain. Instituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC/University of Seville / CIBERSAM, ISCIII, Seville, Spain

    8 shared publications
  • Miguel Ruiz-Veguilla

    Biomedical Research Center in Mental Health Network (CIBERSAM), Health Institute Carlos III, Madrid, SpainMental Health Service, Virgen del Rocío University Hospital; Seville, SpainInstituto de Biomedicina de Sevilla (IBiS) HUVR/CSIC, University

    7 shared publications
  • Rosa Ayesa-Arriola

    Department of Psychiatry. Marqués de Valdecilla University Hospital, IDIVAL, CIBERSAM, ISCIII, School of Medicine, University of Cantabria, Santander, Spain

    7 shared publications
  • Claudio Alemán-Morillo

    Department of Medical Physiology and Biophysics, Faculty of Medicine, University of Seville; Seville, Spain

    6 shared publications
  • Javier Vázquez-Bourgon

    Biomedical Research Center in Mental Health Network (CIBERSAM), Health Institute Carlos III, Madrid, SpainDepartment of Psychiatry. Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria; Santander, Spain

    5 shared publications

Latest Publications

  • Open Access

    Early deviations from normative brain morphology and cortical microstructure in schizophrenia spectrum disorders

    by Claudio Alemán-Morillo, Natalia García-San-Martín, Richard Ai Bethlehem, Patricia Segura, Chloé Gomez, Alessia Pasquini, Pablo Salguero-Quirós, Lena Dorfschmidt, Manuel Muñoz-Caracuel, Rosa Ayesa-Arriola, et al.

    In schizophrenia spectrum disorders (SSD), structural alterations of the gray matter (GM) and white matter (WM) have been widely described. However, the complex interplay between early disease-related changes and ongoing brain maturation challenges our ability to identify early biomarkers. In this study, we investigated structural abnormalities and their association with symptoms in a drug-naïve or minimally medicated sample comprising 113 patients with SSD and 112 neurotypical controls. Specifically, we derived centile scores using normative modelling from cortical thickness (CT), and subcortical volumes derived from structural MRI images, and diffusion tensor imaging-derived (DTI) WM tract fractional anisotropy (FA). In addition, we derived raw cortical mean diffusivity (cMD) metrics from DTI. Compared to controls, SSD participants showed reduced CT centiles, ventricular enlargement, and subcortical centile reductions in the hippocampus, thalamus, amygdala, and nucleus accumbens. SSD was also associated with widespread increases in cMD. We also explored associations among these structural markers, identifying significant relationships between CT centiles and raw cMD, as well as between subcortical centiles and FA tract-based centiles. No interaction with SSD diagnosis was found. Furthermore, positive symptoms correlated negatively with CT and FA tract-based centiles, and showed widespread positive associations with raw cMD, whereas negative symptoms showed no associations. These findings underscore multimodal brain abnormalities that originate early in the course of SSD and their distinct associations with symptoms. Our results support the potential of both normative modelling and diffusion imaging markers to identify individualized early brain changes in SSD Among these, cMD emerges as a potential marker of SSD-related microstructural alterations.

  • Open Access

    Long-term morphometric similarity gradients relate to cortical hierarchy and psychiatric symptoms in schizophrenia

    by Natalia García-San-Martín, Richard Ai Bethlehem, Isaac Sebenius, Leonardo Cardoso Saraiva, Patricia Segura, Claudio Alemán-Morillo, ChloÉ Gomez, Pablo Salguero-Quirós, Alessia Pasquini, Marcella Montagnese, et al.

    Schizophrenia spectrum disorders (SSD) are characterized by altered brain structure, reflecting widespread dysconnectivity across brain-specific networks. However, the role of hierarchical organization on cortical morphometric networks in shaping clinical outcomes over the course of the disease remains unclear. Connectome-derived gradients have increasingly been used to investigate spatial transitions in brain organization. Here, we computed cortical and subcortical Morphometric INverse Divergence (MIND) similarity networks from 1293 structural MRI data of 193 healthy controls (HC) and 350 individuals with SSD followed for up to 20 years. MIND features were calculated for each subject-specific network by computing regional averages and performing gradient decomposition. We found that MIND was longitudinally associated with treatment duration and medication in SSD. These associations were co-localized with hierarchical axes of cortical organization and schizophrenia epicenters. Moreover, psychiatric symptoms were associated with these alterations in structural similarity, which were also related to treatment duration. Collectively, these findings advance our understanding of how brain organization, treatment duration, and medication shape clinical symptoms throughout the course of SSD.


  • Open Access

    Structural similarity networks reveal brain vulnerability in dementia

    by Marcella Montagnese, Amir Ebneabbasi, Natalia García‐San‐Martín, Clara Pecci‐Terroba, Rafael Romero‐García, Sarah E. Morgan, James H. Cole, Jakob Seidlitz, Timothy Rittman, Richard A. I. Bethlehem

    INTRODUCTION: Alzheimer's disease (AD) is characterized by inter‐individual heterogeneity in brain degeneration, limiting diagnostic and prognostic precision. We present a novel framework integrating Morphometric Inverse Divergence (MIND) networks with hierarchical Bayesian large‐scale population modeling to identify individual‐level neuroanatomical deviations. METHODS: MIND networks quantify similarity between brain regions using multivariate magnetic resonance imaging (MRI) features. A normative model of regional MIND values trained on UK Biobank ( N = 35,133) was applied to the National Alzheimer's Coordinating Center cohort ( N = 3,567). We examined brain deviations across clinical stages, apolipoprotein E (APOE) genotypes, mortality risk, and neuropathological burden. RESULTS: Negative deviations (reduced MIND) stratified disease stages ( p < 0.01) and were concentrated in specific functional networks in AD. Greater negative deviations characterized APOE ε4 homozygotes and correlated with post mortem neuropathological severity ( p = 0.032). Spatially, deviation patterns were associated with maps of neurotransmitter receptor density. DISCUSSION: This population neuroimaging modeling enables individualized brain mapping with direct utility for diagnosis, prognosis, and understanding of biological mechanisms. Highlights: MIND networks were systematically integrated with normative modeling in AD. Negative deviations stratify clinical stages and correlate with neuropathology. Negative deviation count distinguishes APOE genotypes, highest in ε4 homozygotes. Deviations align with neurotransmitter maps. Individual brain maps enable precision medicine approaches in dementia.


  • Open Access

    Medication and atypical brain maturation in psychosis associated with long-term cognitive decline and symptom progression

    by Claudio Alemán-Morillo, Natalia García-San-Martín, Richard A. I. Bethlehem, Lena Dorfschmidt, María Alemany-Navarro, Patricia Segura, Alessia Pasquini, Manuel Muñoz-Caracuel, Manuel Canal-Rivero, Jakob Seidlitz, et al.

    Background: Clinical progression during psychosis has been closely associated with grey matter abnormalities resulting from atypical brain development. However, the complex interplay between psychopathology and heterogeneous maturational trajectories challenges the identification of neuroanatomical features that anticipate symptomatic decline. Aims: To investigate cortical volume longitudinal deviations in first-episode psychosis (FEP) using normative modelling, exploring their relationship with long-term cognitive and symptomatic outcomes, as well as their cytoarchitectural and neurobiological underpinnings. Method: We collected magnetic resonance imaging (MRI), cognitive and symptomatic data from 195 healthy controls and 357 drug-naïve or minimally medicated FEP individuals that were followed up 1, 3, 5 and 10 years following the first episode (1209 MRI scans and assessments in total). Using normative modelling, we derived subject-specific centile scores for cortical volume to investigate atypical deviations in FEP and their relationship to long-term cognitive and symptomatic deterioration. The resulting centile association maps were further characterised by examining their cytoarchitectural and neurobiological attributes using normative atlases. Results: FEP centiles demonstrated a widespread reduction at treatment initiation, with longitudinal analysis showing an increase during treatment time, indicating convergence towards normal maturation trajectories. Interestingly, this effect was reduced in highly medicated individuals. Additionally, we found that cognitive impairments experienced during early FEP stages worsened under long-term medication. Positive symptomatology was negatively associated with regional centiles, and individuals with higher centiles benefited most from treatment. Cytoarchitectural and neurobiological analyses revealed that regional centiles related to FEP, as well as to symptomatology, were associated with specific molecular features, such as regional serotonin and dopamine receptor densities. Conclusions: Collectively, these findings underscore the potential use of centile-based normative modelling for a better understanding of how atypical cortical development contributes to the long-term clinical progression of neurodevelopmental conditions.


  • Open Access

    Reduced brain structural similarity is associated with maturation, neurobiological features, and clinical status in schizophrenia

    by Natalia García-San-Martín, Richard Ai Bethlehem, Patricia Segura, Agoston Mihalik, Jakob Seidlitz, Isaac Sebenius, Claudio Alemán-Morillo, Lena Dorfschmidt, Golia Shafiei, Sarah E. Morgan, et al.

    Schizophrenia spectrum disorders (SSD) are characterized by atypical brain maturation, including alterations in structural similarity between regions. Using structural MRI data from 195 healthy controls (HC) and 352 individuals with SSD, we construct individual Morphometric INverse Divergence (MIND) networks. Compared to HC, individuals with SSD mainly exhibit reduced structural similarity in the temporal, cingulate, and insular lobes, being more pronounced in individuals exhibiting a ‘poor’ clinical status (more impaired cognitive functioning and more severe symptomatology). These alterations are associated with cortical hierarchy and maturational events, locating MIND reductions in higher-order association areas that mature later. Finally, we map 46 neurobiological features onto MIND networks, revealing a high presence of neurotransmitters and astrocytes, along with decreased metabolism and microstructure, in regions with reduced similarity in SSD. These findings provide evidence on the complex interplay between structural similarity, maturational events, and the underlying neurobiology in determining clinical status of individuals with SSD.


  • Open Access

    Predicting clinical and functional trajectories in individuals with first-episode psychosis by baseline deviations in grey matter volume

    by Manuel Muñoz-Caracuel, Claudio Alemán-Morillo, Natalia García-San-Martín, Nathalia Garrido-Torres, María Alemany-Navarro, Richard A. I. Bethlehem, Lena Dorfschmidt, Jakob Seidlitz, Rosa Ayesa-Arriola, Javier Vázquez-Bourgon, et al.

    Background: Predicting long-term outcome trajectories in psychosis remains a crucial and challenging goal in clinical practice. The identification of reliable neuroimaging markers has often been hindered by the clinical and biological heterogeneity of psychotic disorders and the limitations of traditional case-control methodologies, which often mask individual variability. Recently, normative brain charts derived from extensive magnetic resonance imaging (MRI) data-sets covering the human lifespan have emerged as a promising biologically driven solution, offering a more individualised approach. Aims: To examine how deviations from normative cortical and subcortical grey matter volume (GMV) at first-episode psychosis (FEP) onset relate to symptom and functional trajectories. Method: We leveraged the largest available brain normative model ( N > 100 000) to explore normative deviations in a sample of over 240 patients with schizophrenia spectrum disorders who underwent MRI scans at the onset of FEP and received clinical follow-up at 1, 3 and 10 years. Results: Our findings reveal that deviations in regional normative GMV at FEP onset are significantly linked to overall long-term clinical trajectories, modulating the effect of time on both symptom and functional outcome. Specifically, negative deviations in the left superior temporal gyrus and Broca’s area at FEP onset were notably associated with a more severe progression of positive and negative symptoms, as well as with functioning trajectories over time. Conclusions: These results underscore the potential of brain developmental normative approaches for the early prediction of disorder progression, and provide valuable insights for the development of preventive and personalised therapeutic strategies.


  • Open Access

    Reduced brain structural similarity is associated with maturation, neurobiological features, and clinical status in schizophrenia

    by Natalia García-San-Martín, Richard Ai Bethlehem, Patricia Segura, Agoston Mihalik, Jakob Seidlitz, Isaac Sebenius, Claudio Alemán-Morillo, Lena Dorfschmidt, Golia Shafiei, Sarah E. Morgan, et al.

    Schizophrenia spectrum disorders (SSD) are characterized by atypical brain maturation, including alterations in structural similarity between regions. Using structural MRI data from 195 healthy controls (HC) and 352 individuals with SSD, we construct individual Morphometric INverse Divergence (MIND) networks. Compared to HC, individuals with SSD mainly exhibit reduced structural similarity in the temporal, cingulate, and insular lobes, being more pronounced in individuals exhibiting a ‘poor’ clinical status (more impaired cognitive functioning and more severe symptomatology). These alterations are associated with cortical hierarchy and maturational events, locating MIND reductions in higher-order association areas that mature later. Finally, we map 46 neurobiological features onto MIND networks, revealing a high presence of neurotransmitters and astrocytes, along with decreased metabolism and microstructure, in regions with reduced similarity in SSD. These findings provide evidence on the complex interplay between structural similarity, maturational events, and the underlying neurobiology in determining clinical status of individuals with SSD.


  • Open Access

    Molecular and micro-architectural mapping of gray matter alterations in psychosis

    by Natalia García-San-Martín, Richard A. I. Bethlehem, Agoston Mihalik, Jakob Seidlitz, Isaac Sebenius, Claudio Alemán-Morillo, Lena Dorfschmidt, Golia Shafiei, Víctor Ortiz-García de la Foz, Kate Merritt, et al.

    The psychosis spectrum encompasses a heterogeneous range of clinical conditions associated with abnormal brain development. Detecting patterns of atypical neuroanatomical maturation across psychiatric disorders requires an interpretable metric standardized by age-, sex- and site-effect. The molecular and micro-architectural attributes that account for these deviations in brain structure from typical neurodevelopment are still unknown. Here, we aggregate structural magnetic resonance imaging data from 38,696 healthy controls (HC) and 1256 psychosis-related conditions, including first-degree relatives of schizophrenia (SCZ) and schizoaffective disorder (SAD) patients (n = 160), individuals who had psychotic experiences (n = 157), patients who experienced a first episode of psychosis (FEP, n = 352), and individuals with chronic SCZ or SAD (n = 587). Using a normative modeling approach, we generated centile scores for cortical gray matter (GM) phenotypes, identifying deviations in regional volumes below the expected trajectory for all conditions, with a greater impact on the clinically diagnosed ones, FEP and chronic. Additionally, we mapped 46 neurobiological features from healthy individuals (including neurotransmitters, cell types, layer thickness, microstructure, cortical expansion, and metabolism) to these abnormal centiles using a multivariate approach. Results revealed that neurobiological features were highly co-localized with centile deviations, where metabolism (e.g., cerebral metabolic rate of oxygen (CMRGlu) and cerebral blood flow (CBF)) and neurotransmitter concentrations (e.g., serotonin (5-HT) and acetylcholine (α4β2) receptors) showed the most consistent spatial overlap with abnormal GM trajectories. Taken together these findings shed light on the vulnerability factors that may underlie atypical brain maturation during different stages of psychosis.


  • Open Access

    Molecular and micro-architectural mapping of gray matter alterations in psychosis

    by Natalia García-San-Martín, Richard Ai Bethlehem, Agoston Mihalik, Jakob Seidlitz, Isaac Sebenius, Claudio Alemán-Morrillo, Lena Dorfschmidt, Golia Shafiei, Víctor Ortiz-García de la Foz, Kate Merritt, et al.

    The psychosis spectrum encompasses a heterogeneous range of clinical conditions associated with abnormal brain development. Detecting patterns of atypical neuroanatomical maturation across psychiatric disorders requires an interpretable metric standardized by age-, sex- and site-effect. The molecular and micro-architectural attributes that account for these deviations in brain structure from typical neurodevelopment are still unknown. Here, we aggregate structural magnetic resonance imaging data from 38,696 healthy controls (HC) and 1,256 psychosis-related conditions, including first-degree relatives of schizophrenia (SCZ) and schizoaffective disorder (SAD) patients ( n = 160), individuals who had psychotic experiences ( n = 157), patients who experienced a first episode of psychosis (FEP, n = 352), and individuals with chronic SCZ or SAD ( n = 587). Using a normative modeling approach, we generated centile scores for cortical gray matter (GM) phenotypes, identifying deviations in regional volumes below the expected trajectory for all conditions, with a greater impact on the clinically diagnosed ones, FEP and chronic. Additionally, we mapped 46 neurobiological features from healthy individuals (including neurotransmitters, cell types, layer thickness, microstructure, cortical expansion, and metabolism) to these abnormal centiles using a multivariate approach. Results revealed that neurobiological features were highly co-localized with centile deviations, where metabolism (e.g., cerebral metabolic rate of oxygen (CMRGlu) and cerebral blood flow (CBF)) and neurotransmitter concentrations (e.g., serotonin (5-HT) and acetylcholine (α 4 β 2 ) receptors) showed the most consistent spatial overlap with abnormal GM trajectories. Taken together these findings shed light on the vulnerability factors that may underlie atypical brain maturation during different stages of psychosis.